Suppr超能文献

过去二十年欧洲甲型肝炎的发生与暴发:一项系统综述。

Hepatitis A occurrence and outbreaks in Europe over the past two decades: A systematic review.

作者信息

Andani Anar, Bunge Eveline, Kassianos George, Eeuwijk Jennifer, Mellou Kassiani, Van Damme Pierre, Mukherjee Piyali, Steffen Robert

机构信息

GSK, Wavre, Belgium.

Pallas Health Research and Consultancy, Rotterdam, the Netherlands.

出版信息

J Viral Hepat. 2023 Jun;30(6):497-511. doi: 10.1111/jvh.13821. Epub 2023 Mar 17.

Abstract

Hepatitis A (HA) is a vaccine-preventable liver disease with >170 million new cases occurring yearly. In recent outbreaks in the USA, hospitalization and case-fatality ratios were >60% and ~1%, respectively. In Europe, endemicity persists and outbreaks continue to occur. We performed a systematic literature review to understand the changes in HA occurrence in Europe over the past two decades. PubMed and Embase were systematically searched for peer-reviewed articles published between 1 January 2001 and 14 April 2021 using terms covering HA, 11 selected European countries, outbreaks, outcomes and HA virus circulation. Here, we focus on HA occurrence and outbreaks in the five countries with the largest population and the most comprehensive vaccination recommendations: France, Germany, Italy, Spain and the UK; 118 reports included data for these five European countries. Notification rates (≤9.7/100,000 population) and percentages of men among cases (≤83.0%) peaked in 2017. The number of person-to-person-transmitted cases and outbreaks decreased in children but increased in other risk groups, such as men who have sex with men (MSM). Sexually transmitted outbreaks in MSM clustered around 2017. Travel-related outbreaks were few; the proportion of travel-related cases decreased during the past two decades, while the number of domestic cases increased. Despite the existing risk-based vaccination recommendations, HA transmission shifted in proportions from travelers and children to other risk groups, such as MSM and older age groups. Because a substantial proportion of the European population is susceptible to HA, adherence to existing recommendations should be monitored more closely, and enhanced vaccination strategies should be considered.

摘要

甲型肝炎(HA)是一种可通过疫苗预防的肝脏疾病,每年新增病例超过1.7亿例。在美国最近的疫情中,住院率和病死率分别超过60%和1%左右。在欧洲,地方性流行持续存在,疫情仍不断发生。我们进行了一项系统的文献综述,以了解过去二十年欧洲甲型肝炎发病情况的变化。我们系统检索了PubMed和Embase数据库,查找2001年1月1日至2021年4月14日期间发表的同行评议文章,检索词涵盖甲型肝炎、11个选定的欧洲国家、疫情、结局以及甲型肝炎病毒传播情况。在此,我们重点关注人口最多且疫苗接种建议最全面的五个国家(法国、德国、意大利、西班牙和英国)的甲型肝炎发病情况和疫情;118份报告包含了这五个欧洲国家的数据。报告率(≤9.7/10万人口)和病例中男性的比例(≤83.0%)在2017年达到峰值。儿童中人际传播的病例数和疫情有所减少,但在其他风险群体中有所增加,例如男男性行为者(MSM)。男男性行为者中的性传播疫情在2017年左右较为集中。与旅行相关的疫情很少;在过去二十年中,与旅行相关的病例比例下降,而国内病例数增加。尽管有现有的基于风险的疫苗接种建议,但甲型肝炎的传播比例已从旅行者和儿童转向其他风险群体,如男男性行为者和老年人群体。由于欧洲相当一部分人口易感染甲型肝炎,应更密切地监测对现有建议的遵守情况,并考虑加强疫苗接种策略。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验